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Surgery for breast cancer has changed in the last few decades in 
favor of more conservative approaches, without compromising loco‐
regional control and survival. Common immediate complications fol‐
lowing breast surgery are hematoma, seroma, and wound infection.1 
Traditionally, surgeons have implemented the use of closed‐suction 
drains in this setting with the aim of preventing these complications, 
which can cause discomfort, morbidity, increased follow‐up visits, 
and possible delay in the beginning of adjuvant therapies.2 On the 
other hand, potential benefits of performing breast procedures 
without using a drain have been increasingly considered.3 There is 
lack of modern and official guidelines on use of drains in breast sur‐
gery, with no consensus regarding their management and the appro‐
priate use of antibiotics in this setting. Almost all reports agree with 
the use of drains after breast procedures, especially if they are asso‐
ciated with reconstruction or axillar lymph node dissection (ALND), 
but an extreme variability is reported regarding practice patterns.4
A national survey regarding the management of drains after 
breast cancer surgery was sent by email on January 2018 to all 
Breast Centers (BC) registered with Senonetwork Italia. Data col‐
lected by the administrative office of Senonetwork were de‐iden‐
tified and exported for statistical analysis. A Steering Committee 
composed of general surgeons and plastic surgeons was appointed 
to coordinate the survey, which consisted of 22 multiple choice 
questions, designed to inquire about surgeons' demographics, use 
of drains after breast procedures with and without reconstruction 
and/or ALND, antibiotic use and to characterize drain management 
in their clinical practice.
A total of 105 BC, performing more than 40 000 breast cancer 
cases each year, were surveyed electronically and 73 complete re‐
sponses were returned (72%).
All 73 evaluable respondents described themselves as breast 
surgeons, among whom 48 (63%) performed both breast cancer sur‐
gery and reconstruction. Most respondents (n = 34; 45%) reported 
that more than 300 cases of breast cancer operations were per‐
formed in their BC each year.
In cases of breast conservative surgery, 18 (25%) BC affirmed 
that they use “always” a drain, 19 (26%) “never,” and 36 (49%) “some‐
times.” The choice of the latest answer was often associated with the 
increased volume of the breast, the quantity of breast parenchyma 
asportation, the need of glandular flap for oncoplastic purpose, and 
the presence of high‐risk factors for hematoma and/or seroma.
Drains after mastectomy were used in 96% (n = 70) of cases, 
while 4% (n = 3) of respondents affirmed that they used drains only 
if mastectomy was associated with breast reconstruction.Senonetwork Italia Breast Centres Responders are present in Appendix 1. 
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In cases of implant‐based breast reconstruction, 51 (70%) BCs 
used two drains, one placed in the submuscular pocket and one in 
the subcutaneous space. When only one drain was used (30%), it 
was placed subcutaneously or in the submuscular pocket in 16% and 
in 14% of cases, respectively.
If ALND was associated with a mastectomy, one, two, or three 
drains were used in 3%, 60%, and 37%, respectively.
The gauge of drains used was 14‐16 Fr in 56% of cases, <14 Fr in 
15%, while more than 16 Fr in 29% of cases.
Respondents stated that hospitalization was not prolonged for 
the presence of drains and that discharge of the patients occurred 
24 hours after the operation in 50% of cases, while they affirmed 
that drains “sometimes” affect hospitalization by two to three days, 
or “always” prolonged it more than three days in 43% and 7% of 
cases, respectively.
A dedicated nurse service was involved in the drain management 
in 57 (78%) cases, while in 16 (22%) this was not present.
Shoulder immobilization after ALND and/or breast reconstruc‐
tion was not adopted by 56 (77%) BC, while shoulder immobilization 
was “always” or “sometimes” applied in 12 (16%) and 5 (7%) cases, 
respectively.
Drains were removed when 24 hours output was <50cc, <30cc, 
after 24 hours, and after 4‐7 days in 55%, 34%, 3%, and 8% of cases, 
respectively.
Sixty‐six (90%) respondents reported adopting a routine practice 
of using antibiotics beyond 24 hours, while 7 (10%) BC did not use 
postoperative antibiotic prophylaxis.
Among respondents who reported postoperative prophylactic 
antibiotic use, the duration of treatment was variable. Antibiotic 
prophylaxis for “2‐5 days” or “until all drains were removed” was re‐
ported in 53% and 22% of cases, respectively, especially if breast 
reconstruction was performed.
Many differences were found among postoperative antibiotics. 
First‐generation cephalosporins, second‐ or third‐generation cepha‐
losporins, amoxicillin plus clavulanic acid, and fluoroquinolones were 
used in 25%, 25%, 34%, and 7% of cases, respectively.
When asked to comment about the clinical relevance of drains 
both in the present and in the future, 88% of respondents reported 
that, nowadays, drains are of clinical relevance in breast surgery, and 
63% stated that they will continue to be important in the next future.
We report the first national survey in Italy regarding the use of 
drains in breast cancer surgery.
Data showed that the use of drains was associated with a pro‐
longed hospitalization in 50% of BC. This finding is consistent with 
an analysis of five systematic reviews which concluded that the in‐
sertion of a drain is associated with a longer hospital stay and re‐
duced seroma formation.5
Half of BC surveyed removed drains when the 24 hours output 
was <50cc. To date, the correct “timing” of the removal of drains 
remains unclear and literature reports do not provide precise indi‐
cations. Some studies, especially in the setting of breast reconstruc‐
tion, show evidence supporting late removal (<30 mL drainage in 
24 hours or postoperative day 14),6 while others stress the advan‐
tages of early removal (postoperative day 2, regardless of volume).7
Antibiotic use has always been an important topic in breast 
surgery. In a survey of the American Society of Breast Surgeons 
(ASBrS), cephalosporins were utilized uniformly as preoperative 
antibiotic prophylaxis.8 This is consistent with the Surgical Care 
Improvement Project guidelines established in 2005 and con‐
firmed in 2015.9 In our survey, this recommendation was adopted 
by only 25% of BC.
Use of postoperative antibiotic prophylaxis has been strongly 
associated with the presence of immediate breast reconstruction 
after mastectomy. Despite a Cochrane study, a meta‐analysis and 
recent guideline's recommendations stated that for clean and 
clean‐contaminated procedures additional prophylactic antimicro‐
bial agents should not be administered after the surgical incision is 
closed in the operating room, even in the presence of a drain,10 our 
survey confirmed this lack of uniformity regarding both the timing 
of antibiotic discontinuation and the type of antibiotic eventually 
used.
In this national survey, we report a large variability regarding 
drain use in the breast conservative setting. After mastectomy or 
axillary node dissection, drains are usually employed and generally 
removed when 24 hours output was <50cc. Consistent with litera‐
ture data, their use has still an impact on the hospital length of stay. 
Surgeons generally continue antibiotic prophylaxis during the 24 
perioperative hours and antibiotic use is still controversial regard‐
ing both the timing of discontinuation and the type used, despite 
precise guidelines present in literature. Furthermore, according to 
our results, most surveyed surgeons believe drains play a clinically 
relevant role in breast surgery and that they will continue to have 
importance in the future.
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APPENDIX 1
SENONET WORK ITALIA BRE A ST CENTRES 
RESPONDERS
Sergio Abonante, Cosenza—Azienda Ospedaliera Cosenza; Vittorio 
Altomare, Roma—Policlinico Universitario Campus Bio‐Medico; 
Claudio Amanti, Roma—A.O. Sant'Andrea Sapienza Università di 
Roma; Luciana Ambrosiani, Como—Ospedale Valduce; Claudio 
Andreoli, Castellanza—Humanitas Mater Domini (VA); Alberto 
Bafile, L'Aquila—Ospedale San Salvatore; Bettina Ballardini, 
Milano—Multimedica S.P.A.; Maggiorino Barbero, Asti—Ospedale 
Cardinal Massaia; Claudio Battaglia, Sanremo—Ospedale Civile 
Di Sanremo (IM); Anna Bianchi, Brescia—Spedali Civili Di Brescia; 
Laura Biganzoli, Prato—ASL Toscana Centro, Ospedale S Stefano 
Prato; Marina Bortul, Trieste—Dipartimento Scienze Mediche 
Chirurgiche e della Salute (DSMCS) Trieste‐ASUITS, Ospedale 
di Cattinara; Patrizia Bravetti, Ravenna—Centro Prevenzione 
Oncologica; Stefano Burlizzi, Brindisi—Ospedale A. Perrino; Carlo 
Cabula, Cagliari—C.R.O. di Riferimento “A. Businco”; Claudio Caponi, 
Empoli—Ospedale S Giuseppe ASL Toscana Centro (FI); Francesco 
Caruso, Catania—Humanitas Centro Catanese Di Oncologia; Carla 
Cedolini, Udine—Azienda Sanitaria Universitaria Integrata; Ettore 
Cianchetti, Chieti Ortona—G. Bernabeo; Fabio Corsi, Pavia—Istituti 
Clinici Scientifici Maugeri IRCCS ‐ Milano, Dipartimento di Scienze; 
Biomediche e Cliniche L. Sacco, Università degli Studi di Milano; 
Annalisa Curcio, Forlì—Ausl Forlì; Olindo Custodero, Bari—Breast 
Unit Ospedale San Paolo Asl Bari; Francesco D'Errico, Monza—
Policlinico Di Monza; Secondo Folli, Milano—Fondazione IRCCS 
Istituto Nazionale dei Tumori di Milano; Lucio Fortunato, Roma—
Azienda Ospedaliera San Giovanni‐Addolorata; Duilio Francesconi, 
Lido Di Camaiore—Ospedale Versilia Usl Toscana Nord Ovest (LU); 
Antonio Frassoldati, Ferrara—Cona Arcispedale S. Anna; Patrizia 
Frittelli, Roma—Fatebenefratelli Isola Tiberina; Daniele Generali, 
Cremona—Azienda Socio‐Sanitaria Territoriale di Cremona; Riccardo 
Giovanazzi, Monza—Ospedale San Gerardo; Massimo Maria Grassi, 
Bergamo—Humanitas Gavazzeni; Alessandra Huscher, Brescia—
Fondazione Poliambulanza; Maria Grazia Lazzaretti, Carpi—Ospedale 
Ramazzini (MO); Francesco Leone, Catanzaro—Azienda Ospedaliera 
Pugliese‐Ciaccio; Gianfranco Lolli, Foligno—San Giovanni Degli 
Infermi ‐ Foligno (PG); Carla Magni, Lecco—SSD “Breast Unit” ASST 
Lecco; Pietro Mainente, Vicenza ‐Schio—Ospedale Alto Vicentino‐
Centro Donna; Luigi Manca, Lecce—Città Di Lecce Hospital; Stefano 
Mancini, Milano—A.O. Polo Universitario Luigi Sacco; Samuele 
Massarut, Aviano—Centro di Riferimento Oncologico di Aviano 
(PN); Alberto Massocco, Negrar—IRCCS Sacro Cuore Don Calabria, 
Negrar, Verona (VR); Lorenzo Menghini, Santarcangelo Di Romagna—
Ospedale degli Infermi di Rimini (RN); Maria Mirri, Roma—Asl Roma 
1 ‐ Ospedale S. Spirito ‐ S. Filippo Neri; Guido Mondini, Ivrea—Breast 
Unit Ovidio Paino Aslto4 (TO); Massimo Monti, Roma—Policlinico 
Umberto Primo; Roberto Murgo, San Giovanni Rotondo—IRCCS 
Casa Sollievo Della Sofferenza (FG); Maria Grazia Pacquola, 
Tortona—S.O.S. Senologia Tortona Asl Alessandria (AL); Adriana 
Paduos, Biella‐Ponderano—Asl Biella; Gianmatteo Pagani, Milano—
Divisione di Senologia Chirurgica ‐ Istituto Europeo di Oncologia; 
Claudio Pagliari, Desenzano—Azienda Ospedaliera Desenzano 
del Garda (VR); Dante Palli, Piacenza—Ospedale Guglielmo Da 
Saliceto; Guido Papaccio, Venezia—Ospedale All'angelo Mestre e SS 
Giovanni E Paolo; Matteo Passamonti, Lodi—Azienda Socio Sanitaria 
Territoriale (ASST) di Lodi; Alba Pellegrini, Faenza—Presidio Faenza 
Ausl Romagna (RA); Francesca Pellini, Verona—Azienda Ospedaliera 
Universitaria Integrata Verona; Francesca Pietribiasi, Moncalieri—
Asl TO 5 Ospedale Santa Croce (TO); Cosmo Maurizio Ressa, 
Bari—IRCCS Istituto Tumori Giovanni Paolo II Bari; Fabio Ricci, 
Latina—Ospedale S. M. Goretti; Manuela Roncella, Pisa ‐ Azienda 
Ospedaliero Universitaria Pisana; Francesca Rovera, Varese—
Asst‐Settelaghi Ospedale di Circolo Varese; Corrado Rubino, 
Salerno—A.O.U. San Giovanni di Dio e Ruggi D'Aragona; Enzo Maria 
Ruggeri, Viterbo—Ospedale Belcolle Ausl Viterbo; Antonio Rulli, 
Perugia—Azienda Ospedaliero‐Universitaria Di Perugia; Alessandro 
Sanguinetti, Terni—Azienda Ospedaliera Terni; Maurizio Saturno, 
Potenza—Azienda Ospedaliera Regionale San Carlo; Giuliano Scalco, 
Vicenza—Ospedale Civile San Bortolo; Adele Sgarella, Pavia—
Fondazione IRCCS Policlinico San Matteo Pavia; Paolo Stefanini, 
Cinisello Balsamo—Istituti Clinici di Perfezionamento Bassini 
Sesto (MI); Francesca Svegliati, Roma—A.O.S.Camillo‐Forlanini; 
Mario Taffurelli, Bologna—Policlinico di Sant'Orsola ‐ Bologna; 
Giovanni Tazzioli, Modena—Policlinico Di Modena; Corrado Tinterri, 
Rozzano—Humanitas Cancer Center (MI); Martino Trunfio, Napoli—
Ospedale Cardarelli; Pasquale Zagarese, Benevento—A.O San Pio 
Benevento.
